In Brazil Market for Breast Cancer Drugs to Grow 40% in 4 Years

    Cancer treatment

    Cancer treatment The breast cancer drug market in Brazil will grow from US$ 424 million in 2009 to US$ 611 million in 2014, says Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues.

    Factors promoting the market’s growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.

    “The value of the Brazilian breast cancer drug market in 2009 (US$ 424 million) rivals those in some major pharmaceutical markets like United Kingdom and Japan and greatly exceeds breast cancer drug sales in other emerging markets (China, India, Russia),” stated Decision Resources’ Therapeutic Area Director Kate Hohenberg.

    “A well-established public healthcare system that pays the cost of drug therapy for eligible patients and a small but lucrative pool of privately insured patients support Brazil’s sizeable breast cancer drug  market.”

    The new Emerging Markets report entitled Breast Cancer in Brazil also finds that given the drawbacks and limitations of current treatments and Brazilian physicians’ enthusiasm for novel approaches in hard-to-treat patient segments (e.g., triple-negative breast cancer), emerging breast cancer therapies will be well received in Brazil.

    Two novel agents – Roche’s trastuzumab-DM1 and Sanofi-Aventis’s BSI-201 – are expected to launch in Brazil towards the end of 2014.

    “By the end of our five-year forecast period (2009-2014), we expect two novel breast cancer agents to launch in Brazil – Roche’s trastuzumab-DM1 and Sanofi-Aventis’s BSI-201. These launches will be facilitated by the low regulatory hurdle (additional domestic clinical trials are not required) and physicians’ receptivity to new therapies for underserved segments of the breast cancer market,” added Ms. Hohenberg.

    The new reports features extensive primary research of physicians and epidemiology study, with analysis of trends in major Brazilian cities – Rio de Janeiro, São Paulo, Brasília, Belo Horizonte, Curitiba and Salvador – and the country overall.

    Tags:

    • Show Comments (1)

    • eco plaques

      That’s good to hear. More help for those in need.

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Up and Coming

    Yes, there are prosperous and even rich Brazilian blacks. And they are not just ...

    Brazil's heliconia

    Brazil’s Tropical Flower Growers Hopeful to Get European Clients Back

    Twenty tropical flower growers from the state of Alagoas want to start exporting again ...

    Why Lula Should Be in the White House

    It’s hard not to think the world would be a better place if Lula ...

    Golden Lesson

    Like the Spanish explorers to the north in Central America, the Portuguese came to ...

    Interest Rate Fears Bring Brazil Market Down

    Brazilian and Latin American stocks mostly declined, as Brazil’s market fell sharply on interest ...

    Half of Brazil’s Corporate Shares Are Bought by Foreigners, Mainly from the EU

    Foreign investors were responsible for 45-50% of the transactions effectuated to acquire shares of ...

    Jobs Up, Real Wages Down in Sí£o Paulo, Brazil

    Unemployment in the metropolitan region of São Paulo, Brazil’s largest city, fell in September ...

    Bus and Gas Up Brazilian Inflation 0.59% in January

    Brazil’s Broad Consumer Price Index (IPCA) rose to 0.59% in January, after having reached ...

    Brazil Shares Info on Information with South Africa

    A team from the Brazilian Ministry of Education will travel this month to South ...